PFGIA
EGRX

Patriot Financial Group Insurance Agency’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5
Closed – – 2027
2020
Q3 		$0 Buy
+5
New +$219 ﹤0.01% 1884

Other funds holding EGRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Patriot Financial Group Insurance Agency's EGRX Position: Q4 2020 in Review

Patriot Financial Group Insurance Agency sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2020, closing a stake of 5 shares.

Patriot Financial Group Insurance Agency first reported a position in EGRX in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 166 funds tracked by Wall St. Rank hold EGRX as of Q4 2020.

  • Patriot Financial Group Insurance Agency reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 5 Eagle Pharmaceuticals, Inc. shares in Q4 2020.
  • Patriot Financial Group Insurance Agency first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Patriot Financial Group Insurance Agency's Eagle Pharmaceuticals, Inc. position peaked at $0 in Q3 2020.
  • 166 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q4 2020, filed 15 Jan 2021.